Advertisement
Home »

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.

Apr 10, 2023

ABOUT THE CONTRIBUTORS

  • Chad A Bousman

    Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences, University of Calgary, Alberta, Canada.

    Alberta Children’s Hospital Research Institute, University of Calgary, Alberta, Canada.

    Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada.

    James M Stevenson

    Departments of Medicine and Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

    Laura B Ramsey

    Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

    Divisions of Clinical Pharmacology and Research in Patient Services, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA.

    Katrin Sangkuhl

    Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.

    J Kevin Hicks

    Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL, USA.

    Jeffrey R Strawn

    Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.

    Divisions of Child & Adolescent Psychiatry and Clinical Pharmacology Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA.

    Ajeet B Singh

    School of Medicine, IMPACT Institute, Deakin University, Australia.

    Gualberto Ruaño

    Institute of Living at Hartford Hospital, Hartford, CT, USA.

    Department of Psychiatry, University of Connecticut School of Medicine, Hartford, CT, USA.

    Daniel J Mueller

    Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

    Department of Psychiatry, University of Toronto, Ontario, Canada.

    Evangelia Eirini Tsermpini

    Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000, Ljubljana, Slovenia.

    Jacob T Brown

    Department of Pharmacy Practice & Pharmaceutical Sciences, University of Minnesota College of Pharmacy, Duluth, MN, USA.

    Gillian C Bell

    Genome Medical, South San Francisco, CA, USA.

    J Steven Leeder

    Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy Research Institute (CMRI), Kansas City, MO, USA.

    School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.

    Andrea Gaedigk

    Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children’s Mercy Research Institute (CMRI), Kansas City, MO, USA.

    School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.

    Stuart A Scott

    Department of Pathology, Stanford University, Palo Alto, CA, USA.

    Stanford Medicine Clinical Genomics Program, Stanford Medicine, Stanford, CA, USA.

    Teri E Klein

    Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.

    Kelly E Caudle

    Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA.

    Jeffrey R Bishop

    Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, USA.

    Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, MN, USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement